Trial Profile
A Study to Evaluate the Adalimumab and Anti-Adalimumab Antibodies Serum Levels and Their Association with Clinical and Laboratory Response in Patients With Crohn's disease (CD)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Dec 2015
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Crohn's disease
- Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 28 Dec 2015 New trial record